European Society for Medical Oncology Preceptorship on Gastric Cancer 2023 Valencia PDF

10 $

+ Include: 24 pdfs, size: 59.3 MB

+ Target Audience: oncologist

Description

+ Include: 24 pdfs, size: 59.3 MB

+ Target Audience: oncologist

+ Sample video: contact me for sample video

+ Information:

Start date: 29 Sep 2023
End date: 30 Sep 2023
Location: Valencia, Spain

Learning objectives

  • To learn about the fundamentals of epidemiology, aetiology, pathogenesis, molecular events and immune biology of gastric and esophago-gastric junction cancer
  • To understand the essentials in the diagnosis and multidisciplinary treatment of gastric cancer
  • To learn about advances in the treatment and novel targets in gastric cancer

 

+ Topics:

Biologically Targeted Treatment (HER2, Claudin 18.2, FGFR2, and Beyond).pdf
Clinically Useful Pathology Biomarkers (with some genomics!).pdf
ESMO-Preceptorship-on-Gastric-Cancer-2023-Valencia-Programme.pdf
Gastric Cancer as a Global Problem.pdf
Genomics and Pathology of Hereditary Cancers.pdf
Immunotherapy for Advanced Gastroesophageal Adenocarcinoma.pdf
Participants Clinical Case Discussion – A Case of a Patient with Oesophago-gastric Junction (OGJ) Adenocarcinoma in Stage IV- A Therapeutic Continuum.pdf
Participants Clinical Case Discussion – A Perioperative Dilemma.pdf
Participants Clinical Case Discussion – Addition of Durvalumab to Perioperative and Maintenance Therapy in Localised Advanced Cancer- Report of a Case.pdf
Participants Clinical Case Discussion – Case Discussion- Immune Mediated Colitis.pdf
Participants Clinical Case Discussion – dMMR Elderly Patient Treated with Nivolumab.pdf
Participants Clinical Case Discussion – From stage IV to CR- An HER2 fairytale.pdf
Participants Clinical Case Discussion – Management of Oligometastatic Disease in Oesophago-Gastric Adenocarcinoma.pdf
Participants Clinical Case Discussion – Multimodal Treatment of Locally Advanced GEJ Cancer.pdf
Participants Clinical Case Discussion – Neoadjuvant Immunotherapy for MSI-HdMMR Gastric Cancer.pdf
Participants Clinical Case Discussion – Post-FLOT Progression in PDL1 Gastric Cancer.pdf
Participants Clinical Case Discussion – Recurrent Bleeding in Frail Patient with Gastric Cancer.pdf
Participants Clinical Case Discussion – The Role of Cytoreductive Surgery and HIPEC in Gastric Cancer with MSI-H Phenotype.pdf
Particular Aspects in Patients with Squamous Cell Histology (Peri-Operative and Advanced).pdf
Perioperative Treatment for Gastric Cancer- State of the Art and Current Controversies.pdf
Radiation Therapy for Gastric Cancer, and Oesophago-Gastric Junction Cancer.pdf
Sequential Chemotherapy (Doublet, Triplet, Elderly Patients, Sequences, Anti-Angiogenic Therapy, Oral Cchemotherapy).pdf
Surgery for Gastric and EG Junction Cancer, Primary, Palliative – Where and When.pdf
Welcome from ESMO and Introduction.pdf

Reviews

There are no reviews yet.

Be the first to review “European Society for Medical Oncology Preceptorship on Gastric Cancer 2023 Valencia PDF”

Your email address will not be published. Required fields are marked *